[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368577-105":59,"doc-detail-368577-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","current-perspectives-on-mesenchymal-dendritic-cell-neoplasms-of-lymphoid-tissue-insights-into-ontogeny-updates-on-classification-and-clinicopathologic-characteristics","Current Perspectives on Mesenchymal Dendritic Cell Neoplasms of Lymphoid Tissue - Insights into Ontogeny, Updates on Classification, and Clinicopathologic Characteristics","","Mesenchymal dendritic cell neoplasms are rare hematologic malignancies that strain traditional histiocytic and classical dendritic/Langerhans cell frameworks. Formerly grouped within broader dendritic cell categories, they differ in ontogeny, histopathology, molecular alterations, and clinical behavior. The review organizes three subtypes—follicular dendritic cell sarcoma, fibroblastic reticular cell tumor, and EBV-positive inflammatory variants—and emphasizes mesenchymal stromal origin. It highlights NF-κβ pathway activation, the need for immunophenotypic discrimination, and two case studies illustrating diagnostic pitfalls that support refined nomenclature and accurate classification for timely management.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/current-perspectives-on-mesenchymal-dendritic-cell-neoplasms-of-lymphoid-tissue-insights-into-ontogeny-updates-on-classification-and-clinicopathologic-characteristics/368577/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/current-perspectives-on-mesenchymal-dendritic-cell-neoplasms-of-lymphoid-tissue-insights-into-ontogeny-updates-on-classification-and-clinicopathologic-characteristics/368577.png","ImageObject",300,407,{"name":92,"@type":93},"วิน","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are mesenchymal dendritic cell neoplasms and why do they challenge existing classifications?","Question",{"text":112,"@type":113},"They are rare tumors arising from stromal cells of lymphoid tissue and historically grouped under dendritic cell neoplasms. Their distinct ontogeny, pathology, molecular changes, and clinical behavior create overlap with other dendritic and related entities, complicating diagnosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are the three main subtypes covered in the review?",{"text":117,"@type":113},"The review describes follicular dendritic cell sarcoma, fibroblastic reticular cell tumor, and EBV-positive inflammatory follicular dendritic cell sarcoma/fibroblastic reticular cell tumor variants.",{"name":119,"@type":110,"acceptedAnswer":120},"Which diagnostic approach is emphasized to distinguish these tumors from other hematologic malignancies?",{"text":121,"@type":113},"Immunophenotypic characterization is highlighted as critical, along with careful integration of current classification concepts, ontogeny, and clinicopathologic evaluation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368577,1790568096,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Review  \nCurrent Perspectives on Mesenchymal Dendritic Cell Neoplasms of Lymphoid Tissue: Insights into Ontogeny, Updates on Classification, and Clinicopathologic Characteristics  \nNeha Seth 1, Jithma P. Abeykoon 2, Gaurav Goyal 3, Ronald S. Go 2, Steven Tessier 4, Rebecca L. King 5 and Aishwarya Ravindran 6, *  \nAcademic Editor: Huey-Jen Lin  \nReceived: 15 May 2025  \nRevised: 16 June 2025  \nAccepted: 17 June 2025  \nPublished: 19 June 2025  \nCitation: Seth, N.; Abeykoon, J.P.; Goyal, G.; Go, R.S.; Tessier, S.; King, R.L.; Ravindran, A. Current Perspectives on Mesenchymal Dendritic Cell Neoplasms of Lymphoid Tissue: Insights into Ontogeny, Updates on Classification, and Clinicopathologic Characteristics. Cancers 2025, 17, 2055. [https://](https://)[ ](https://)[doi.org/10.3390/cancers17122055](doi.org/10.3390/cancers17122055)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11548, USA  \n2 Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA  \n3 Division of Hematology/Medical Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA  \n4 Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education, Rochester, MN 55905, USA  \n5 Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA  \n6 Division of Laboratory Medicine-Hematopathology Section, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35249, USA  \n* Correspondence: [aravindran@uabmc.edu](aravindran@uabmc.edu)  \nSimple Summary: Mesenchymal dendritic cell neoplasms are rare tumors that arise from stromal cells of lymphoid tissue, comprising three different subtypes including follicular dendritic cell sarcoma, fibroblastic reticular cell tumor, and EBV-positive inflammatory follicular dendritic cell sarcoma/fibroblastic reticular cell tumor. These tumors are biologically distinct from histiocytic and classical dendritic/Langerhans cell neoplasms that originate from hematopoietic precursors. The existing classifications of hematopoietic tumors create an overlap of these mesenchymal dendritic cell neoplasms with classical dendritic cell neoplasms and plasmacytoid dendritic cell neoplasms, resulting in diagnostic challenges in clinical practice. The purpose of this review is to provide insights into their ontogeny, detail their clinicopathologic features, and clarify their nomenclature in order to refine our understanding and enable accurate diagnosis of these entities.  \nAbstract: Mesenchymal dendritic cell neoplasms represent a distinct category of hematologic malignancies that challenge traditional classifications of histiocytic and classical dendritic/Langerhans cell neoplasms. Historically grouped under the broader umbrella of dendritic cell neoplasms, these entities differ significantly in their ontogeny, histopathologic features, molecular alterations, and clinical behavior. They are categorized into three main subtypes including follicular dendritic cell sarcoma, fibroblastic reticular cell tumor, and EBV-positive inflammatory follicular dendritic cell sarcoma/fibroblastic reticular cell tumor. They originate from mesenchymal stromal cells, and genetic alterations activating the NF- κβ pathway are frequent in follicular dendritic cell sarcomas. Immunophenotypic characterization is critical to distinguish these from other hematologic malignancies including histiocytic and classical dendritic/Langerhans cell neoplasms and other solid (non-hematopoietic) cancers. This r","cbCaikTnzxhmaLwJ","https://ap.wps.com/l/cbCaikTnzxhmaLwJ","pdf",7200074,23,"English","# Introduction\n# Mesenchymal-derived stromal cells in lymphoid tissue\n# Subtypes and conceptual classification\n# Ontogeny and molecular alterations\n# Immunophenotypic characterization and differential diagnosis\n# Clinicopathologic features and case studies\n# Conclusions and diagnostic implications","[{\"question\":\"What are mesenchymal dendritic cell neoplasms and why do they challenge existing classifications?\",\"answer\":\"They are rare tumors arising from stromal cells of lymphoid tissue and historically grouped under dendritic cell neoplasms. Their distinct ontogeny, pathology, molecular changes, and clinical behavior create overlap with other dendritic and related entities, complicating diagnosis.\"},{\"question\":\"What are the three main subtypes covered in the review?\",\"answer\":\"The review describes follicular dendritic cell sarcoma, fibroblastic reticular cell tumor, and EBV-positive inflammatory follicular dendritic cell sarcoma/fibroblastic reticular cell tumor variants.\"},{\"question\":\"Which diagnostic approach is emphasized to distinguish these tumors from other hematologic malignancies?\",\"answer\":\"Immunophenotypic characterization is highlighted as critical, along with careful integration of current classification concepts, ontogeny, and clinicopathologic evaluation.\"}]","Current Perspectives on Mesenchymal Dendritic Cell Neoplasms of Lymphoid Tissue - Insights into Ontogeny, Updates on Classification, and Clinicopathologic Characteristics | PDF",1790177552,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb3edcb5314d5526d8f767eb673204c5.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36199b2e75a8345d65873e59652cf7d9.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5ccd0bc3ed31d0a3c070eae123e4b73.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ceaaa5bde512edc31f3cbca25634dfdc.webp",980,1385]